Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Aryl triazines as LPAAT-β inhibitors and uses thereof

Aryl triazines as LPAAT-β inhibitors and uses thereof

US Patent 7618968 · Granted Nov 17, 2009

Estimated economic value: $37,879,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Alkoxy compounds for disease treatment2024
Synthesis of coelenterazine2024
Synthesis of coelenterazine2024
Alkoxy compounds for disease treatment2022
Synthesis of coelenterazine2021
Synthesis of coelenterazine2021
GPR119 agonist compounds2021
Compounds as GPR119 agonists2021
GPR119 agonist compounds2020
Alkoxy compounds for disease treatment2020
Compounds as GPR119 agonists2020
GPR119 agonist compounds2019